Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Expert Review of Respiratory Medicine|January 10, 2020
Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectivesCarlo Genova, Giovanni Rossi, Marco Tagliamento, et al.
Critical Reviews in Oncology/Hematology|July 26, 2020
Coronavirus infection and immune system: An insight of COVID-19 in cancer patientsAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Immunotherapy|June 4, 2019
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosusMarco Tagliamento, Francesco Grossi, Sabrina Paolino, et al.
Annals of Gastroenterology|November 21, 2022
Immune checkpoint inhibitor therapy for hepatocellular carcinomaDaryl Ramai, Alexandra Shapiro, Antonio Facciorusso, et al.
Endocrine|March 7, 2019
RETRACTED ARTICLE: Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label studyStefano Gay, Giovanni Rossi, Giuliana Corica, et al.
Expert Review of Gastroenterology & Hepatology|August 23, 2021
Metabolic disorders and the risk of cholangiocarcinomaMichele Ghidini, Daryl Ramai, Antonio Facciorusso, et al.
Viruses|April 3, 2021
The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic ScoreMichele Ghidini, Alice Indini, Erika Rijavec, et al.
Melanoma Research|May 20, 2024
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanomaAlice Indini, Rossana Gueli, Michele Cerati, et al.
Expert Opinion on Biological Therapy|April 18, 2012
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancerCarlo Genova, Erika Rijavec, Giulia Barletta, et al.
Expert Opinion on Investigational Drugs|June 5, 2019
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compoundsMarco Tagliamento, Carlo Genova, Giovanni Rossi, et al.
Pageof 10